Drug Markets/Abrocitinib

Abrocitinib

1 NDC across 1 manufacturer|0 Generic,1 Brand

Abrocitinib is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jan 14, 2022. In 2024, Medicare Part D spent $17 million on Abrocitinib across 2,728 claims for 536 beneficiaries.

Abrocitinib is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $197.09 to $197.09 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$197.09 – $197.09

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ABROCITINIB

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
CIBINQO 100 MG TABLET
$197.0924
per EA
—

Frequently Asked Questions

What is Abrocitinib used to treat?

Abrocitinib is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Abrocitinib?

In 2024, Medicare Part D spent $17 million on Abrocitinib across 2,728 claims for 536 beneficiaries.

How many Abrocitinib products are on the market?

The Abrocitinib drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Abrocitinib?

NADAC reference prices for Abrocitinib range from $197.0924 to $197.0924 per EA.

Which manufacturers make Abrocitinib?

1 manufacturer lists Abrocitinib in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (1).